Clinical Trials Logo

Filter by:
NCT ID: NCT05078216 Completed - Clinical trials for Cancer Patients in Different Stages

How to Carry on an Effective Community Program of Exercice-oncology.

Start date: September 1, 2018
Phase:
Study type: Observational

Exercise-oncology is an emerging area, but exist a lack of information about an effective methodology to establish counseling programs long-lasting and not based on research objectives. This observational study objective was to evaluate the feasibility and effective exercise-oncology community intervention in a real patients sample.

NCT ID: NCT05076656 Completed - Obesity Clinical Trials

Epigenetic and Microbiota Modifications

EPI-MICROBIO
Start date: June 10, 2019
Phase: Early Phase 1
Study type: Interventional

In order to investigate how gut microbiota interventions are able to change gut microbiota population and impact insulin resistance, 30 type2 diabetes volunteers with obesity will be randomized to one of the three treatment groups: 1) probiotics arm, who will take a Lactobacillus fermentum D3 in pills daily; 2) FMT arm, who will take a lyophilized fecal microbiota transplant in pills; and 3) control group, who will take placebo pills. After 3 months, insulin resistance, glucose metabolism parameters, and gut microbiota variation will be assessed.

NCT ID: NCT05076032 Completed - Infertility Clinical Trials

Phase II Clinical Trial to Evaluate the Ongoing Pregnancy Rate With OXO-001 in IVF/ICSI With Donor Oocytes.

OXOART2
Start date: September 1, 2021
Phase: Phase 2
Study type: Interventional

The main objective of this clinical research trial is to test the efficacy of OXO-001 in a daily oral administration increasing the pregnancy rate in IVF/ICSI by preparing the uterus to receive the embryo.

NCT ID: NCT05075408 Completed - Clinical trials for Chronic Kidney Disease Associated Moderate to Severe Pruritus

To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus

NemoCKDaP
Start date: December 29, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of nemolizumab compared to placebo at reducing the intensity of pruritus after a 12-week treatment period in adult hemodialysis participants with moderate to severe pruritus.

NCT ID: NCT05073510 Completed - Clinical trials for Peripheral Arterial Disease

Clinical Evaluation of the BlueDop Vascular Expert for Assessing Peripheral Arterial Disease

Start date: October 11, 2021
Phase:
Study type: Observational

This is a BlueDop Vascular Expert System (BVE) Post-Market Clinical Follow-Up (PMCF) study. The primary objective of the study is to assess the clinical applicability and diagnostic accuracy of the BVE device in subjects who require an arterial duplex test due to suspected peripheral arterial disease (PAD).

NCT ID: NCT05072574 Completed - Clinical trials for Chronic Kidney Diseases

Quality of Life, Nutritional Status and Functional Capacity in People With Advanced Chronic Kidney Disease

ERCANUT
Start date: April 23, 2021
Phase: N/A
Study type: Interventional

This study evaluates the clinical response (quality of life, nutritional status, functional capacity, and disease knowledge) of advanced CKD patients who undergo an individualized dietary intervention and a nutritional education program (group workshops) using motivation coaching techniques, compared to controls who receive general hygiene-nutritional education at every visit.

NCT ID: NCT05071404 Completed - Clinical trials for Inflammatory Bowel Diseases

Efficacy Assessment and Monitoring of Subcutaneous Infliximab Levels.

Infliximab
Start date: November 1, 2020
Phase:
Study type: Observational

Retrospective observational study in which the efficacy of infliximab is studied in patients with inflammatory bowel disease and its subcutaneous levels are monitored.

NCT ID: NCT05071391 Completed - Obesity Clinical Trials

Autophagy and Inflammasome in Obesity: Effect of Weight Loss and Potential Therapeutic Implications

Start date: January 1, 2017
Phase:
Study type: Observational

The main aim of this project is to determine the implication of autophagy and inflammasome in the pathogenesis of obesity and related comorbidities, and to explore in depth the mechanisms associated with the activation of immune cells leading early stages of the atherosclerotic process and metabolic disease. The hypothesis of the present study is that weight loss mediated by Roux-en-Y gastric bypass (RYGB) improves the protein expression of markers of autophagy and inflammation within immune cells. Moreover, the investigators will explore the association of these mechanisms with the mitochondrial function and dynamics, Endoplasmic Reticulum (ER) stress an intracellular nutritional status of leukocytes (measured by fluorescence microscopy and western blot). Further, the potential relationship between changes in the mentioned intracellular pathways and systemic pathological mechanisms including oxidative stress, inflammation and glucose and lipid metabolism will be explored. Hence, serum carbonylated proteins, myeloperoxidase (MPO) levels, antioxidant enzymatic activities including SOD (Superoxide dismutase) and catalase, circulating cytokines, and glucose and lipid metabolism parameters will be evaluated in a cohort of obese subjects before and 12 months after RYGB intervention.

NCT ID: NCT05070546 Completed - Clinical trials for Respiratory Syncytial Virus Infection Prevention

A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Start date: September 29, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to investigate the safety and immunogenicity of the Ad26.RSV.preF based vaccine in adults 18 to 59 years of age who are healthy or at risk for severe Respiratory Syncytial Virus (RSV) disease, compared to adults 65 years and above.

NCT ID: NCT05068050 Completed - Arthritis Clinical Trials

Multicenter, Randomized Trial to Determine the Effect of Therapeutic Riding, on a Group of People With Arthritis

ARTHER
Start date: September 15, 2021
Phase: N/A
Study type: Interventional

The aim of this job is to evaluate the possible changes in the state of health of 10 indi-viduals diagnosed with arthritis who follow a standardised Therapeutic Riding treatment, as an experimental group, versus 10 patients who follow a standardised physical exercise programme. The intervention guidelines for both groups are established in a programme of 12 ses-sions in total, 6 weeks in duration, twice a week and a duration of 45 minutes each ses-sion. The effectiveness of the intervention program will be evaluated in terms of pain, joint mobility, static and dynamic balance, gait, capacity for effort and quality of sleep.